$M

Macy’s stock price target held at $10 by UBS on market share concerns

UBS maintained a Sell rating and $10 price target on Macy’s (M) due to market share losses and weak sales. Despite better-than-expected Q2 earnings, UBS expects earnings pressure and lower estimates. Macy’s Q2 revenue was $4.9B, with adjusted EPS of $0.63. Analysts have mixed views on its turnaround strategy.

Original reporting
Published Sep 17, 2026, 1:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 2:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$M
Bearish
medium confidence
Mentioned
$M
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$MBearishMed
01

Why it matters

The reaffirmed sell rating and $10 target reinforce a bearish outlook, likely limiting upside in the near term.

02

Market read

Analyst downgrade may influence short-term price action for Macy's and could affect sentiment in the broader retail sector.

03

What to watch

Potential upside from turnaround initiatives and improved cash flow not fully reflected in the target.

Relevance 6/10Novelty 5/10Timing: pre-market today

Background

Macy's reported modest sales growth and an earnings beat driven by tariff refunds, but analysts remain concerned about market share loss.

Company-level read

Ticker impact

$MBearishMedium confidence
Context

UBS reiterated a Sell rating on Macy's and kept its $10 price target despite the recent Q2 earnings beat.

Expected impact

Potential short-term downside as investors reassess valuation.

Evidence & confidence

The sell rating and unchanged low target suggest limited upside, reinforcing bearish sentiment.

Market effects

Retail sector may face broader scrutiny as analysts highlight market share challenges.

U.S. consumer discretionary stocks could see modest pressure.

Limited to U.S. markets; no direct global effect.

Counterpoint

Some investors may view the price target as overly pessimistic given the earnings beat.

Key entities

  • Macy's

    U.S. department store chain (ticker M).

  • UBS

    Investment bank providing the sell rating and price target.

Related articles

$MMed

This Questionable Berkshire Hathaway Holding Actually Makes Sense

Berkshire Hathaway's investment in Macy's, a brick-and-mortar retailer, may seem questionable but shows potential. Macy's sales have stabilized, with same-store sales growing 2.7% last quarter, and the company raised its full-year revenue and earnings guidance. Analysts expect revenue to decline slightly but predict efficiency gains will boost earnings. Berkshire's stake, now 7.4 million shares, could be a turnaround play rather than a real estate bet, with Macy's trading at a low P/E ratio of 8

$MMed

Macy's (M) Raises Guidance And Finishes Buyback, Is The Stock Still Below Fair Value?

Macy's (M) reported earnings, raised guidance, and completed a multiyear buyback. The stock is down 6.84% in 30 days and 10.36% in 90 days, but up 27.25% in 1 year and 2.3x in 3 years. Analysts estimate a fair value of $22.77, slightly above the current $21.64, suggesting a small discount. The company's growth in luxury and off-price segments supports future revenue growth, but e-commerce competition and margin pressures remain concerns.

$MHighAI 8/10

Macy’s Earnings Call Signals Turnaround Momentum

Macy's (M) reported Q2 earnings that surpassed expectations, with revenue up 1.1% to $4.9B and adjusted EPS at $0.63. Comparable sales rose 2.7% across Macy's, Bloomingdale's, and Bluemercury. Management highlighted margin expansion, cash flow improvements, and strategic initiatives, while raising full-year guidance. However, third-quarter outlook remains cautious with flat-to-slightly-negative comps and a small EPS loss.

$MHighAI 8/10

Macy’s: Q2 Net Sales Rise To $4.9 Billion As Comparable Sales Gain 2.7% And FY2026 Guidance Increases

Macy's reported Q2 2026 net sales of $4.9B, up 1.1% YoY, with comparable sales rising 2.7%. All major brands saw growth, with Bloomingdale's up 11.3%. Gross margin increased to 41.5%, and net income nearly doubled. The company raised its FY2026 guidance for sales, EBITDA margin, and EPS. Macy's ended the quarter with $1.3B in cash and $2B in available credit.

$MHighAI 8/10

Macy’s Posts Strong Financial Results And Raises Guidance

Macy’s (M) reported Q2 earnings of $0.40 per share, beating estimates, with revenue of $4.87B. Comparable sales rose 2.7%, with Bloomingdale’s and Bluemercury seeing significant gains. The company raised full-year guidance to $21.68B-$21.83B in sales and $2.15-$2.35 in EPS. M stock rose 4% premarket.

$MHighAI 9/10

Macy’s Raises Full Year Outlook After Strong Q2 — Says Inventories ‘Well-Positioned’ Heading Into Second Half Of 2026

Macy's Inc. (M) reported Q2 net sales of $4.9B, up 1.1%, and adjusted EPS of $0.63, beating estimates. Comparable sales rose 1.1%, with Bloomingdale's up 11.3%. The company raised its FY26 outlook, expecting net sales of $21.675B-$21.825B and adjusted EPS of $2.15-$2.35. Inventories increased 2.5% YoY, deemed well-positioned. Stock was down 3% premarket.